Improvements in body mass index of children with cystic fibrosis following implementation of a standardized nutritional algorithm: A quality improvement project

被引:2
作者
Gokdemir, Yasemin [1 ,5 ]
Eralp, Ela Erdem [1 ]
Ergenekon, Almala Pinar [1 ]
Yegit, Cansu Yilmaz [1 ]
Yanaz, Muruvvet [1 ]
Mursaloglu, Hakan [2 ,3 ]
Uzunoglu, Burcu [3 ]
Kocamaz, Damla [3 ]
Tastan, Gamze [3 ]
Filbrun, Amy [4 ]
Enochs, Catherine [4 ]
Bouma, Sandra [4 ]
Iwanicki, Courtney [4 ]
Karakoc, Fazilet [1 ]
Nasr, Samya Z. [4 ]
Karadag, Bulent [1 ]
机构
[1] Marmara Univ, Div Pediat Pulmonol, Sch Med, Istanbul, Turkiye
[2] Kings Coll Hosp London, Dept Emergency Med, London, England
[3] Marmara Univ, Selim Coremen Cyst Fibrosis Ctr, Sch Med, Istanbul, Turkiye
[4] Univ Michigan, Div Pediat Pulmonol, Ann Arbor, MI USA
[5] Marmara Univ Hosp, Div Pediat Pulmonol, Fevzi Cakmak Mah Mimar Sinan Cad 10, TR-34899 Pendik Istanbul, Turkiye
关键词
body mass index; children; cystic fibrosis; nutrition; OF-LIFE; MEDICAL-PRACTICE; HEALTH-CARE; PATTERNS; OUTCOMES;
D O I
10.1002/ppul.26344
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundA collaboration between the University of Michigan (UM) Cystic Fibrosis Center (CFC) and Marmara University (MU) CFC was initiated in MU through conducting Quality Improvement projects (QIP). The global aim was to improve nutritional status of children with CF (cwCF), with a specific aim to increase the mean BMI percentile (BMIp) for cwCF by 10 percentile points in 12 months. MethodsBody mass index (BMI) percentiles of cwCF were categorized as: nutritionally adequate (BMIp >= 50%); at risk (BMIp 25%-49%); urgently at risk (BMIp 10%-25%); critically at risk (BMIp < 10%). Appropriate interventions were made according to BMIp category every three months. Forced expiratory volume in one-second percent predicted (FEV1pp), and health-related quality of life (HRQoL) were evaluated. ResultsOne hundred and eight-two cwCF with a mean age of 9.1 +/- 4.3 years were included in the project. Baseline BMIp increased from 25.6 to 37.2 at the 12th month (p < 0.001). In the critically at-risk group BMIp increased from 3.6 to 20.5 (p < 0.001), in the urgently at risk group from 15.9 to 30.8 (p < 0.001), in the at risk group from 37.0 to 44.2 (p < 0.079) and in the nutritionally adequate group the increase was from 66.8 to 69.5 (p < 0.301). FEV1pp also improved significantly, from 81.3 +/- 20.6 to 85.9 +/- 20.8 (p < 0.001). Physical functioning, eating problems, and respiratory symptoms domains of the HRQoL evaluation improved (p < 0.05). ConclusionThis project has led to significant improvements in BMIp, FEV1pp and HRQoL of cwCF; similar projects could easily be implemented by centers in other developing countries.
引用
收藏
页码:1463 / 1470
页数:8
相关论文
共 34 条
  • [1] Improvements in healthcare: How can we change the outcome?
    Acton, JD
    Kotagal, U
    [J]. JOURNAL OF PEDIATRICS, 2005, 147 (03) : 279 - 281
  • [2] [Anonymous], 2021, PATIENT REGISTRY ANN
  • [3] Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis
    Bodnar, Reka
    Kadar, Laszlo
    Holics, Klara
    Ujhelyi, Rita
    Kovacs, Lajos
    Bolbas, Katalin
    Szekely, Gyongyi
    Gyurkovits, Kalman
    Solyom, Eniko
    Meszaros, Agnes
    [J]. ITALIAN JOURNAL OF PEDIATRICS, 2014, 40
  • [4] Borawska-Kowalczyk Urszula, 2015, Dev Period Med, V19, P127
  • [5] Key findings of the US Cystic Fibrosis Foundation's clinical practice benchmarking project
    Boyle, Michael P.
    Sabadosa, Kathryn A.
    Quinton, Hebe B.
    Marshall, Bruce C.
    Schechter, Michael S.
    [J]. BMJ QUALITY & SAFETY, 2014, 23 : 15 - 22
  • [6] Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool
    Calvo-Lerma, Joaquim
    Boon, Mieke
    Hulst, Jessie
    Colombo, Carla
    Asseiceira, Ines
    Garriga, Maria
    Masip, Etna
    Claes, Ine
    Bulfamante, Anna
    Janssens, Hettie M.
    Roca, Maria
    Vicente, Saioa
    Fornes, Victoria
    Zazzeron, Laura
    van Schijndel, Bo
    Woodcock, Sandra
    Pereira, Luisa
    de Boeck, Kris
    Ribes-Koninckx, Carmen
    [J]. NUTRIENTS, 2021, 13 (06)
  • [7] ceddcozum, US
  • [8] European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre
    Conway, Steven
    Balfour-Lynn, Ian M.
    De Rijcke, Karleen
    Drevinek, Pavel
    Foweraker, Juliet
    Havermans, Trudy
    Heijerman, Harry
    Lannefors, Louise
    Lindblad, Anders
    Macek, Milan
    Madge, Sue
    Moran, Maeve
    Morrison, Lisa
    Morton, Alison
    Noordhoek, Jacquelien
    Sands, Dorota
    Vertommen, Anneke
    Peckham, Daniel
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2014, 13 : S3 - S22
  • [9] A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation
    Davies, Jane C.
    Sermet-Gaudelus, Isabelle
    Naehrlich, Lutz
    Harris, R. Scott
    Campbell, Daniel
    Ahluwalia, Neil
    Short, Christopher
    Haseltine, Eric
    Panorchan, Paul
    Saunders, Clare
    Owen, Caroline A.
    Wainwright, Claire E.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) : 68 - 77
  • [10] Deming WE., 1982, OUT CRISIS